Cognoa

Ep 2: "Focusing on Child Strengths in Autism" with Renae Beaumont PhD. Discover how focusing on strengths, rather than deficits, can transform development for children with #autism. Listen now: https://bit.ly/461MGlw. Don't forget to subscribe on Apple Podcasts, Spotify, and more! #InTheKnowPodcast #Cognoa #AutismAwareness #PediatricCare #ChildDevelopment #Earlyiseverything #autismcare #autismdiagnosis #developmentaldelay #behavioralhealth

Don't miss out! Our latest episode of In the Know, Presented by Cognoa is live! Join us as Dr. Colleen Kraft, experienced pediatrician and Past President of the American Academy of Pediatrics, discusses the vital role of the “Medical Home” in guiding families through the next steps after an #autism diagnosis. Listen now: https://bit.ly/3La8Vfj #InTheKnowPodcast #Cognoa #PediatricCare #AutismAwareness #ChildDevelopment #PodcastReminder #PrimaryCare #ClinicalInsights #Earlyiseverything #autismcare #autismdiagnosis #developmentaldelay #behavioralhealth

Check out our recent episode as we explore how the unique strengths of children with #autism can guide them in overcoming challenges. Missed the episode? Don’t miss out on the full conversation here: https://bit.ly/4cAwwS6 Kelly Wilson Colleen Kraft #InTheKnowPodcast #Cognoa #AutismAwareness #PediatricCare #ChildDevelopment #Earlyiseverything #autismcare #autismdiagnosis #developmentaldelay #behavioralhealth

Highmark Inc. is paving the way for transformative change in how children with early developmental concern are evaluated and diagnosed with #CanvasDx. Highmark's leadership allows more children and families to benefit from a streamlined, accurate, and more equitable approach to diagnosis and early interventions. Learn more about how we are empowering early action on #developmentalconcern, transforming #autismdiagnosis processes and the landscape of pediatric developmental and #behavioralhealthcare, with accessible, data-driven, clinically validated innovation. #nomorewaitlists Read here: https://lnkd.in/dQBh93kc Thank you Highmark Inc. and Timothy L. for your leadership! #Leadership #Digitalhealth #Childdevelopment #Developmentaldelay #AIinhealthcare #Pediatrics #Pediatricinnovation

🌟 Exciting Feature Alert! 🌟 Award-winning clinical psychologist at Weill Cornell Medicine, Renae Beaumont PhD, shares her insights + passions about using clinically validated tech innovations to improve #youthmentalhealth and wellbeing of kids and families. Renae highlights #CanvasDx for early, equitable diagnosis and interventions for #developmentaldelay and #autism, her founding work in #socialemotionallearning with Social Science Translated, and much more! Read the full interview: https://lnkd.in/dtQwiXq2 #DigitalHealth #Innovation #Cognoa #AutismCare #Childdevelopment #Earlychildhooddevelopment #AIhealthcare

Exciting News! The first episode of our podcast series, In the Know, Presented by Cognoa is LIVE! Join us as we discuss "What Happens After an Autism Diagnosis?": Making the Pediatrician an Essential Part of the Treatment Team with the esteemed Colleen Kraft former American Academy of Pediatrics president. Listen now and make sure your practice is ready to support families every step of the way! Don't miss out on future episodes featuring top experts in behavioral and #developmentalhealth. Subscribe to "In the Know" on Apple Podcasts, Spotify, Podbean, and more! #InTheKnowPodcast #Cognoa #AutismAwareness #PediatricCare #ChildDevelopment #Earlyiseverything #autismcare #autismdiagnosis #developmentaldelay #behavioralhealth “What Happens After Diagnosis?”: Making the Pediatrician an Essential Part of the Treatment Team - Cognoa https://bit.ly/3RKPHAK

Check out this article from an autistic psychologist Amy Marschall in Verywell on self-diagnosis and the innovative approach of Cognoa in early, rapid, accessible evaluation of developmental delay and #autism in young children. Their perspective adds a unique dimension to understanding #neurodiversity. Read the full article here: https://bit.ly/4bGxSL5 #AutismAwareness #Neurodiversity #Cognoa #Earlyintervention #earlysignsofautism #earlyiseverything #nomorewaitlists #developmentalconcern

In this interview, FDA head of the Office of Neurological and Physical Medicine Devices David McMullen talks about the tremendous potential to fill critical gaps in care in the #mentalhealth space – sighting #CanvasDx for early evaluation and diagnosis of #autism and #developmentaldelay - amongst others, Rejoyn Medical Systems and Mama Lift Plus. David's message to the #meddevic innovators is "let's work together". Read the full interview here: https://lnkd.in/gnxnD-Un #medicaldevice #digitalhealth #digitaldiagnostics #AIhealth Elizabeth Orr Pharma Intelligence, now Citeline

Excited to have attended the iSPI Meeting, a unique forum for leaders in pediatric innovation. It was a privilege to engage with visionary minds and discuss the future of pediatric healthcare. Animesh Tandon, MD, MS , Todd Ponsky, Tiffani Ghere, Kevin Maher, Anthony Chang, MD, MBA, MPH, MS, and Kevin Dufendach Cognoa #iSPI2024 #PediatricInnovation #HealthcareLeadership #FutureOfHealthcare

I had the pleasure of recently recording a podcast for Healio with my good friend and colleague Hansa Bhargava MD. One of the topics that came up was what was how did pediatric neurologist like myself got involved with both Cognoa leading the way in #autism #neurodevelopment and #behavioralhealth in #pediatrics but also end up advising Cognito Therapeutics, Inc. with a #breakthrough for treatment for #Alzheimers. You'll have to stay tuned to find out and hear about the overlap between #neurodevelopmental and #neurodegenerativediseases. I'm not the only one though, check out this research out of University of Exeter, Radboud University, UMC Utrecht Brain Center, Utrecht University, Heidelberg University, University of Groningen, & Tokyo University of Science from coauthors Martien Kas, J. Peter H. Burbach, Asami Oguro-Ando, Amila Zuko, et al. revealing protein Contactin-4's (CNTN4) role in neuron development and interaction with protein Amyloid Precursor Protein (APP), impacting both #neurodevelopmentaldisorders and #AlzheimersDisease. My summary: >Cntn4 Knockout Mice Cntn4-deficient mice exhibit reduced cortical thickness in the motor cortex region and altered dendrite length and branching in pyramidal neurons. Overexpression of CNTN4 in primary neurons results in significantly longer dendrites, suggesting CNTN4 promotes neurite outgrowth. >CNTN4-APP Interaction Mass spectrometry analysis identified APP as a binding partner of CNTN4. In CNTN4-/-, APP-/-, and CNTN4-/-/APP-/- knockout cells, total neurite length, longest neurite length, and cell area were significantly reduced compared to control cells. This suggests the CNTN4-APP interaction contributes to their gene expression and neurite outgrowth. >Relevance to Neurodevelopmental Disorders Abnormalities in the motor cortex and neurite outgrowth defects observed in Cntn4-deficient mice align with connectivity and phenotypic abnormalities seen in autism. The findings provide insights into the role of CNTN4 and its interplay with APP in neural development, which may be relevant for understanding the etiology of neurodevelopmental disorders like autism and neurodegenerative disorders like Alzheimer's Disease. Read the full text here: https://lnkd.in/ghWN5eYq